Yuichi Mitani
10.1007/s11657-013-0131-6
Arch Osteoporos
2013;8(1):131.
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/23539323/
Anti-Inflammatory Agents / adverse effects Arthritis, Rheumatoid / complications Bone Density Conservation Agents / therapeutic use Femoral Neck Fractures / drug therapy Fractures, Ununited / drug therapy Glucocorticoids / adverse effects Osteoporosis / drug therapy Teriparatide / therapeutic use
Anti-Inflammatory Agents / adverse effects Arthritis, Rheumatoid / complications Bone Density Conservation Agents / therapeutic use Femoral Neck Fractures / drug therapy Fractures, Ununited / drug therapy Glucocorticoids / adverse effects Osteoporosis / drug therapy Teriparatide / therapeutic use Case Reports Aged, 80 and over Anti-Inflammatory Agents / administration & dosage Bone Density Conservation Agents / administration & dosage Cysteine / administration & dosage Cysteine / analogs & derivatives Female Femoral Neck Fractures / chemically induced Glucocorticoids / administration & dosage Humans Osteoporosis / complications Osteoporosis / etiology Prednisolone / administration & dosage Prednisolone / adverse effects Teriparatide / administration & dosage Treatment Outcome Anti-Inflammatory Agents Bone Density Conservation Agents Glucocorticoids Teriparatide Prednisolone Cysteine bucillamine
PMC3889682
23539323
Effective treatment of a steroid-induced femoral neck fracture nonunion with a once-weekly administration of teriparatide in a rheumatoid patient: a case report
2013